Stanniocalcin 1 (STC1) and stanniocalcin 2 (STC2) are two recently identified mammalian peptide hormones. STC1 plays a role in calcium and phosphate homoeostasis, while the role of STC2 is unknown. We examined a human fibrosarcoma cell line, HT1080, that has high steady-state STC1 and STC2 mRNA levels, to determine whether these proteins are secreted. Following incubation of HT1080 cells with $#P, labelled STC1 and STC2 were found to be secreted into the medium. STC1 was phosphorylated in itro by protein kinase C (PKC). In itro and in i o phosphorylation both occurred exclusively on serine and the phosphopeptide maps were similar, suggesting that PKC might be the in i o kinase. STC2 was phosphorylated in itro by casein kinase II (CK2), in itro and in i o phosphorylation were exclusively on serine and the phosphopeptide maps were indistinguishable. Phosphorylation of STC2 in intact cells resulted from the action of an ecto-protein kinase, since exogenous STC2
INTRODUCTION
Stanniocalcin 1 (STC1) is a secreted, dimeric glycoprotein hormone which is a regulator of calcium and phosphate homoeostasis. STC1 stimulates phosphate reabsorption in rat proximal tubules [1] and inhibits Ca# + absorption in swine and rat intestine in itro [1, 2] . STC1 immunostaining and mRNA have been detected in many tissues, including kidneys [3] , ovaries [4] and neurons [5] . STC1 mRNA has also been detected in chondrocytes and osteoblasts, thereby implicating STC1 in endochrondral and membrane bone formation [6] . This ubiquitious expression suggests that mammalian STC1 may have acquired autocrine or paracrine roles, in addition to the classical endocrine function observed with the fish homologue, STC [7] . STC was reported originally to play a major role in calcium and phosphate homoeostasis in fish with bony skeletons [8] .
Stanniocalcin 2 (STC2) is a recently reported STC1 homologue that shares $ 34 % identity with STC1 [9] . STC2 also appears to be widely expressed in mammalian tissues, including pancreas [10, 11] , skeletal muscle [12] and small intestine [9] . The function of STC2 has yet to be fully clarified, but is also likely to relate to calcium and phosphate metabolism. One study, however, demonstrated that the effects of STC2 on phosphate transport in opossum kidney cells are unlike those of STC1. STC2 inhibited phosphate reabsorption by reducing the expression of a renal Na-P i -4 co-transporter [12] .
A variety of other peptide hormones are secreted as phosphoproteins. These include adrenocorticotropin [13] , human choriAbbreviations used : STC1, stanniocalcin 1 ; STC2, stanniocalcin 2 ; PKC, protein kinase C ; CK2, casein kinase II ; MALDI-TOF, matrix-assisted laserdesorption ionization-time of flight ; PKA, cAMP-dependent protein kinase ; CaMPK-II, calmodulin-dependent protein kinase II ; PKG, protein kinase G; MARCKS, myristoylated alanine-rich C-kinase substrate ; cdc2 kinase, p34 cdc2 /cyclin B ; Endo-Lys-C, endoproteinase Lys-C. 1 To whom correspondence should be addressed (e-mail rreddel!cmri.usyd.edu.au).
was phosphorylated by HT1080 cells and no phosphorylated STC2 was detectable inside the cells. The ectokinase activity was abolished by heparin and GTP could substitute for ATP as the phosphate donor, indicative of an ecto-CK2-like activity. The in itro CK2 phosphorylation site was shown by matrix-assisted laser-desorption ionization-time-of-flight MS to be a single serine located between Ser-285 and Ser-298 in the C-terminal region of STC2. This is the first report of the secretion of STC1 or STC2 from mammalian cells. We conclude that these human fibrosarcoma cells express both STC1 and STC2 as secreted phosphoproteins in i o, with STC2 being phosphorylated by an ecto-CK2-like enzyme.
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onic gonadotropin [14] , basic fibroblast growth factor [15] , atrial natriuretic peptide [16, 17] , progastrin [18] , growth hormone [19] and prolactin [20] [21] [22] . Some of these hormones are substrates for intracellular as well as extracellular protein kinases. Atrial natriuretic peptide and basic fibroblast growth factor have been shown to be phosphorylated extracellularly by an ecto-cAMPdependent protein kinase, ecto-PKA, located on the external surface of cells [15, 16] .
In situ hybridization and immunohistochemical staining show the presence of STC1 in a variety of tissues. Therefore, our aim was to determine if endogenous STC1 and STC2 are secreted from mammalian cells. Since a variety of peptide hormones are secreted as phosphoproteins, we also examined the phosphorylation status of secreted STC1 and STC2.
EXPERIMENTAL

Cells, recombinant protein and antibodies
HT1080 cells were obtained from the American Type Culture Collection and maintained in Dulbecco's modified Eagle's medium supplemented with 10 % fetal bovine serum. The cDNAs encoding STC1 and STC2 were PCR-amplified with primers containing restriction-enzyme sites for cloning into the baculovirus expression vector pFastBac1 (Life Technologies, Victoria, Australia). STC1 also contained the epitope tag MRGSH ' at the C-terminus to aid in its purification by metal-affinity chromatography. Recombinant STC1 and STC2 were purified from the medium of baculovirus-infected Sf9 (Spodoptera frugiperda) cells propagated in SF900II medium (Life Technologies). Rabbit polyclonal and mouse monoclonal STC1 antibodies (a generous gift from Dr Yasuhiro Furuichi, AGENE Research Institute, Kanagawa, Japan) were made using recombinant STC1 expressed in Escherichia coli as the antigen. The rabbit polyclonal antibodies were immunoaffinity purified. Polyclonal anti-STC2 antibodies were made in sheep using peptides corresponding to three different regions of the STC2 molecule not represented in STC1 (peptide A, TDATNPPEGPQDRSSQQKG ; peptide B, CSK-SHPNAHARGRVGGLGAQ ; peptide C, CSGSSEWEDEQS-EYSDIRR). Antiserum was purified on a Protein G-Sepharose column (Amersham Pharmacia Biotech, Uppsala, Sweden) followed by affinity purification on a streptavidin column (Pierce, Rockford, IL, U.S.A.) to which biotinylated peptide A was coupled (peptide A was determined by ELISA to be the most immunogenic of the three peptides).
P Labelling of cells and Western blotting
HT1080 cells were plated at 9i10& cells\well in 6-well plates (Becton Dickinson, Franklin Lakes, NJ, U.S.A.) and grown overnight. The following day the cells were rinsed three times with PBS, then incubated with 200 µCi\ml $#P (9000 Ci\mmol ; Amersham, Victoria, Australia) in fresh Dulbecco's modified Eagle's medium without fetal bovine serum for 24 h at 37 mC. Cell lysates were extracted in RIPA buffer (1 % Nonidet P40, 1 % sodium deoxycholate, 0.0125 M sodium phosphate, pH 7.2, 2 mM EDTA, 0.2 mM sodium vanadate, 50 mM sodium fluoride, 100 units\ml aprotinin, 10 µg\ml leupeptin and 1 µg\ml pepstatin A) at 4 mC for 5 min, followed by centrifugation at 4 mC for 25 min at 14 000 g. Secreted STC1 and STC2 were immunoprecipitated from HT1080-conditioned medium and cellular lysates by adding 1-10 µg of purified polyclonal STC1 or polyclonal STC2 antibodies, respectively, without pre-clearing. The samples were then agitated slowly overnight at 4 mC. Either Protein A-agarose or Protein G-agarose (Pierce) was added to each tube for a further 3 h at 4 mC. Samples were centrifuged and the beads were washed seven times with RIPA buffer before dissolving in a 3iconcentrate of SDS\PAGE sample buffer (0.5 M Tris\HCl, pH 6.8, 28 % glycerol, 6 % SDS, 6 mM EGTA, 25 mM β-mercaptoethanol and 0.7 mg\ml Bromophenol Blue) and heated to 95 mC for 3 min. The samples analysed for carbohydrate moieties were processed differently. After washing with RIPA buffer, the samples were resuspended in 1 % SDS, boiled for 2 min, then 20 mM sodium phosphate, pH 7.2, 10 mM NaN $ , 50 mM Nonidet P40 and 0.5 % n-octylglucoside were added and the samples boiled for an additional 2 min. Once cooled, 0.4 unit of N-glycosidase F (Boehringer Mannheim, Mannheim, Germany) was added and the samples incubated at 37 mC for 16 h. All samples were centrifuged and analysed by SDS\PAGE using 10 or 12 % polyacrylamide gels, followed by transferring to a PVDF membrane (Millipore, Bedford, MA, U.S.A.). Blots were exposed to X-ray film to detect phosphoproteins and were then processed for immunodetection of STC1 or STC2. Membranes were blocked in 3 % BSA in TBS\Tween (10 mM Tris\HCl, pH 7. ; or protein kinase G (PKG) [23] with 10 µM cGMP. A peptide derived from the Walsh inhibitor of PKA [23] , PKI, at 0.01 mg\ml was included in the assays for PKG and PKC to prevent cross-activation by cGMP of any PKA potentially present in the samples. Human recombinant p34 cdc# \ cyclin B (cdc2 kinase) and casein kinase II (CK2) were purchased from Calbiochem. Upon prewarming samples to 37 mC for 5 min, reactions were initiated by addition of 500 ng of recombinant STC1 or STC2, followed by the purified kinase (20-40 ng\ reaction). After 5 min the reactions were terminated by the addition of 50 µl of 3iSDS sample buffer and rapid freezing on dry ice [24] . Phosphorylated STC was resolved using a 7.5-15 % acrylamide-gradient SDS gel (20 cm#, Protean II system, BioRad, Regents Park, New South Wales, Australia).
Ecto-protein kinase assay
Protein kinase assay
Determination of stoichiometry and substrate kinetics utilized similar conditions as described above. However, a time course to determine P i saturation at a fixed protein concentration was utilized for stoichiometric analyses whereas kinetic analyses employed a 10-min incubation at 37 mC along with a broad protein-concentration range. Phosphorylated species were excised from dried gels, counted in a β-counter, and stoichiometry and kinetics were determined. Kinetic constants K m and V max were derived with the PC program Enzfit (written by Robin Leatherbarrow, from Sigma). Myristoylated alanine-rich Ckinase substrate (MARCKS) was isolated and purified from rats as described previously [25] . Stanniocalcin 1 and 2 are secreted phosphoproteins
Phosphoamino acid analysis, phosphopeptide mapping and matrixassisted laser-desorption ionization-time-of-flight (MALDI-TOF) MS
In itro-or in i o-phosphorylated STC1 and STC2 were resolved by SDS\PAGE (12 % gel) and transferred on to a PVDF membrane. The bands were excised using the autoradiograph as a template and hydrolysed in 6 M HCl at 110 mC for 60 min. The samples were then dried in a Speed-Vac Concentrator (Savant, Farmingdale, NY, U.S.A.), dissolved in pyridine\acetic acid\water (5 : 50 : 945, by vol.), pH 3.5, containing unlabelled phosphotyrosine, phosphothreonine and phosphoserine (Sigma) each at 1 mg\ml and the phosphoamino acids were separated by thin-layer electrophoresis as described previously [26] . Phosphopeptide maps using V8 protease (Staphylococcus aureus ; Sigma) were performed on recombinant and native STC1 and STC2 excised from dried gels, digested and peptides were separated by SDS\PAGE (15 % gel) as described previously [27] .
For MS, 50 µg of in itro-phosphorylated STC2 was reduced and carboramidomethylated in situ before being digested with 5 µg of endoproteinase Lys-C (Endo-Lys-C, Lysobacter enzymogenes ; Boehringer Mannheim) for 48 h at 37 mC. The sample was extracted in 1 % trifluoroacetic acid\40 % acetonitrile overnight, dried, resuspended in 200 µl of water and loaded directly on to an HPLC micro reversed-phase chromatography (µRPC) C # \C ") column (Amersham Pharmacia Biotech). Labelled peptides were detected by Cerenkov counting and the fraction containing the highest radioactivity was micro-purified on a Poros R3 column [28] . The sample was analysed by MALDI-TOF MS in linear delayed extraction (LDE) mode (Perkin Elmer-Perseptive Biosystems Voyager DE-STR, Melbourne, Australia). Alkaline phosphatase (Boehringer Mannheim)-treated samples were digested on target with 0.25 unit of alkaline phosphatase in 2 µl of 0.1 M NH % HCO $ , pH 7.8 [29] .
RESULTS
Analysis of 32 P-labelled STC1 and STC2
To study the secretion of the mammalian STCs, it was first necessary to find a cell line that secreted either STC1 or STC2, as no cell lines have been reported to secrete these hormones. The human fibrosarcoma cell line, HT1080, containing a high level of steady-state STC1 mRNA [7] , was found to contain STC2 mRNA (results not shown) and was therefore used in the present study. In addition, the secretion of STC1 and STC2 observed from HT1080 cells was not due to leakage from cellular debris. This was verified by dye exclusion, which showed a 96 % cell viability under experimental conditions (results not shown).
To demonstrate storage and secretion of the STCs, Westernblot analyses were performed on cell lysates and conditioned media from HT1080 cells using specific antibodies to STC1 and STC2 (Figure 1 ). STC1 was produced in high abundance in the cells, detected as a 31-kDa doublet and a minor 33-kDa band ( Figure 1A, lane 3) . Smaller amounts of STC1 were secreted from these cells as a larger 35-kDa form and a 31-kDa form ( Figure 1A, lane 4) . The multiple size forms detected were largely accounted for by glycosylation, as digestion of cellular lysate and conditioned media with N-glycosidase F resulted in an increased mobility for all bands ( Figure 1C) .
The same cells produced and secreted STC2 ; however, the pattern was markedly different from STC1. STC2 was undetectable in the cells by Western blot ( Figure 1B, lane 3) , but significant levels of the 32-kDa protein were detected in a secreted form ( Figure 1B, lane 4) . This suggests that, unlike STC1, newly synthesized STC2 is not stored in the cells, but undergoes constitutive secretion.
To determine if the secreted hormones might be phosphorylated, HT1080 cells were labelled with $#P and either STC1 or STC2 was immunoprecipitated. Autoradiography detected STC1 as a 35-kDa phosphoprotein ( Figure 1A, lane 2) . Phosphorylation of STC1 was only detected in the conditioned medium and the band co-migrated in size with the heavily glycosylated form of STC1 ( Figure 1A, lane 4) . The majority of the cellular STC1 ( Figure 1A, lane 3) did not co-migrate with any 
Figure 4 Phosphoamino acid analysis of in vivo-and in vitro-phosphorylated human STC1 and STC2
Human STCs were either immunoprecipitated with specific anti-STC1 antibodies (A, lane 1) or specific anti-STC2 antibodies (B, lane 1) from 32 P-labelled HT1080-conditioned medium. Recombinant STCs were phosphorylated with PKC (A, lane 2) or CK2 (B, lane 2) using [γ-32 P]ATP as the phosphate donor. The labelled proteins were resolved by SDS/PAGE on a 12 % gel and transferred on to PVDF membranes. The resultant phosphoproteins were then subjected to phosphoamino acid analysis. An autoradiograph is shown with the positions of phosphoserine (P-Ser), phosphothreonine (P-Thr) and phosphotyrosine (P-Tyr) standards on the left. Results are representative of two separate experiments.
$#P-labelled bands ( Figure 1A, lane 1) , although a small amount of the 33-kDa medium glycosylated form might correlate with a $#P-labelled band. Therefore, mainly the secreted form of STC1 was phosphorylated. This phosphorylation may occur as a late event in post-translational processing, with STC1 possibly being phosphorylated during or soon after secretion from the cell.
When polyclonal STC2-specific antibodies were used to immunoprecipitate from labelled HT1080-conditioned medium, a similar result was obtained. No cellular phosphorylation of STC2 was detected ( Figure 1B, lane 1) , but a major secreted phosphoprotein was immunoprecipitated ( Figure 1B, lane 2) that co-migrated with immunoreactive STC2 ( Figure 1B, lane 4) . The phosphorylated STC2 ran as a doublet, with a minor
Figure 5 Comparison of in vivo and in vitro phosphorylation sites
Phosphopeptide mapping with V8 protease of either STC1 (lanes 1 and 2) or STC2 (lanes 3 and 4). The proteins were phosphorylated in vitro by PKC or CK2 (lanes 1 and 3), as indicated above the panel. The proteins were also immunoprecipitated from HT1080-conditioned medium after labelling with 32 P (lanes 2 and 4) as described in the legend for Figure 1 , and visualized by autoradiography. Results are representative of two separate experiments.
amount of a larger-molecular-mass species, that may have been glycosylated.
Phosphorylation of exogenous STC2 by ecto-protein kinases
Since no phosphorylated STC1 or STC2 was detectable in the cellular lysates of labelled HT1080 cells, it seemed likely that the proteins were being phosphorylated during or after secretion. To determine whether an ecto-protein kinase might phosphorylate STC1 or STC2, HT1080 cells were incubated with [γ-$#P]ATP or [γ-$#P]GTP and exogenous recombinant STC was added. Ecto-protein kinase activity was only detectable using STC2 as a substrate (Figure 2) . No intrinsic protein kinase activity was detected in STC2 preparations (Figure 2A, lane 1) , but numerous substrates for ecto-protein kinases associated with HT1080 cells were detected ( Figure 2A, lane 2) . Exogenous STC2 inhibited the phosphorylation of some cell-surface proteins (Figure 2A , compare lane 2 with lanes 3-6), suggesting that they may be substrates for the same enzyme. Protein kinase activators cAMP, cGMP and PMA had no effect on STC2 phosphorylation (Figure 2A, lanes 3-6) . The ecto-protein kinase was strongly inhibited by heparin (Figure 2A, lane 7) . The ecto-protein kinase activity was able to utilize either ATP or GTP equally as phosphate donors (Figures 2A and 2B ). These are two major characteristics of CK2 [30] . To further confirm the existence of an ecto-CK2 kinase, exogenous dephosphorylated casein was substituted for STC2 and was also shown to be phosphorylated by the ecto-protein kinase ( Figure 2C ). In addition, protein kinase activity was released from the surface of intact HT1080 cells upon treatment with dephosphorylated casein (Figure 2D ), consistent with substrate-induced ecto-CK2 kinase release from the surface of other cell types [31] . These results together indicate that the ecto-protein kinase has the characteristics of CK2.
In vitro phosphorylation
To determine which protein kinase(s) phosphorylate STC1 and STC2 in itro, we screened a variety of purified protein kinases. STC1 was a better substrate for PKC than for PKG, and was effectively phosphorylated by four other kinases : the catalytic subunit of PKA, CaMPK-II, CK2 and cdc2 kinase ( Figure 3A) . In contrast, STC2 was a better substrate for CK2 than for all other kinases tested ( Figure 3B) .
The stoichiometry as well as the kinetics of phosphorylation for both STC1 by PKC and STC2 by CK2 were then determined. Using either STC1 or STC2, the calculated stoichiometry was 0.1 mol of P\mol of protein. The kinetics (K m and V max ) of phosphorylation of STC1 by PKC and STC2 by CK2 are summarized and compared with known substrates in Table 1 . When the ratios of V max \K m for both STC1 and STC2 are compared with the calculated V max \K m ratio for the phosphorylation of MARCKS by PKC or the phosphorylation of dephosphorylated casein by CK2, it is clearly evident that both STC1 and STC2 are excellent substrates for PKC and CK2, respectively.
Correlation of in vitro and in vivo phosphorylation
We next determined if the in itro phosphorylation of STC1 and STC2 by PKC and CK2, respectively, was consistent with these protein kinases playing a role in the phosphorylation of the proteins secreted from HT1080 cells. In itro and in i o phosphorylation were compared to determine whether the same amino acids were labelled and whether the proteins were phosphorylated in the same region of the molecule. Phosphoamino acid analysis revealed that both in itro-and in i o-labelled STC1 ( Figure 4A ) and STC2 ( Figure 4B ) were labelled exclusively on serine residues. This is consistent with PKC and CK2 being the in i o protein kinases responsible for STC1 and STC2 phosphorylation, respectively. This also excludes a role of any protein tyrosine kinase. To further correlate in itro and in i o phosphorylation, V8 phosphopeptide mapping was performed. The phosphopeptide map of STC1 revealed that the phosphorylation pattern observed in i o, upon immunoprecipitating labelled STC1 from HT1080-conditioned medium, was strikingly similar to that generated in itro by PKC ( Figure 5, lanes 1 and  2) . The phosphopeptide map of STC2 revealed that the site (or sites) phosphorylated by CK2 in itro was also similar to those phosphorylated by intact HT1080 cells ( Figure 5, lanes 3 and 4) . Stanniocalcin 1 and 2 are secreted phosphoproteins This supports the possibility that the kinases identified as being most active in itro phosphorylate the same site as the in i o protein kinases.
Phosphorylation site in STC2
To determine the phosphorylation site for CK2 in STC2, MALDI-TOF MS was used ( Figure 6 ). A single phosphorylation site was detected which resided in one of the five serines between Ser-285 and Ser-298. STC2 was phosphorylated in itro by CK2 and run on SDS\PAGE. Using autoradiography, the labelled band was excised and digested with Endo-Lys-C for analysis of peptide mass. A number of phosphorylated masses were detected ( Figure 6A ). The largest two were 4058 and 3901 Da and corresponded to the C-terminus of STC2 at STC2 #'' -$!# (with the sequence SHPNAHARGRVGGLGAQGPSGSSEWEDEQSE-YSDIRR) and STC2 #'' -$!" , respectively. Phosphorylation was found to occur on a single residue, as dephosphorylation with alkaline phosphatase reduced the mass of both peptides by 80 Da ( Figure 6B ). Fortuitously, further digestion of STC2 occurred, possibly due to a contaminating peptidase. This yielded a variety of truncated fragments of masses 3622, 3414, 3343, 3187, 3130 and 2976 Da, corresponding to the sequential removal of the Nterminal dipeptide AH followed by the amino acids A, R, G and R respectively. This sequence, AHARGR, corresponds to STC2 #(! -#(& . Every peptide lost 80 Da when dephosphorylated ( Figure 6B ). This supports the conclusion that a single phosphorylation site exists within the C-terminal region of STC2, between Ser-285 and Ser-298 (SGSSEWEDEQSEYS). Of the five serines in this region, Ser-288 (shown in bold) precisely matches the known consensus sequence motif for a CK2 phosphorylation site [32] .
DISCUSSION
We have shown that the human fibrosarcoma cell line, HT1080, secretes both STC1 and STC2 as phosphorylated proteins. This is the first report of any cell line secreting either hormone. It is also particularly interesting that this cell line secretes both. The post-translational processing of the two proteins, however, appears to be regulated differently. STC1 is produced intracellularly in large amounts in lightly glycosylated forms which were not phosphorylated. The secreted form, on the other hand, is not as abundant and is highly glycosylated and phosphorylated. This would suggest that the secretion of STC1 from the cells is regulated, with the lightly glycosylated, unphosphorylated form being stored until arrival of a required external stimulus. In contrast, STC2 is produced in low amounts in the cell, being undetectable by Western blots, and the secreted form is phosphorylated. The low level of intracellular STC2 precursors indicates that the processing and secretion is constitutive in these cells. Thus the regulation of STC1 and STC2 secretion from the same cell are distinct processes, possibly reflecting different biological roles for each protein.
STC2 was shown to be a substrate for an ecto-protein kinase associated with HT1080 cells. No intracellular STC2 phosphorylation was detected and the secreted protein was phosphorylated. The STC2 kinase was shown to be ecto-CK2 by five criteria : heparin inhibition, cyclic nucleotide independence, the ability to equally use ATP or GTP as the phosphate donor, the ability to phosphorylate exogenous casein and shedding of the activity from the cell surface. The ability of the ecto-CK2 protein kinase to be shed from the cell surface is a unique feature and has been shown by the addition of exogenous substrates [31] . In addition, STC2 was phosphorylated in itro by CK2 more strongly than by in bold) is the best candidate for the site for CK2 phosphorylation among the five serine residues in this region [30] . CK2 prefers to phosphorylate serine or threonine in the context of acidic amino acids on the C-terminal side (underlined). A glutamic or aspartic acid three amino acids C-terminal to the phosphorylation site is known to be essential, while further acidic residues contribute to a high V max . CK2 also supports hierarchical phosphorylation, so that phosphorylation of Ser-288 would potentially make Ser-285 a CK2 substrate. This is unlikely to be the case for STC2, however, as only a single phosphate was detected in all peptides derived from the EndoLys-C digest.
The mechanism of STC1 phosphorylation in HT1080 cells was not unequivocally demonstrated. No clear evidence of ectomediated kinase activity was found when using STC1 as a substrate. Therefore, either the phosphorylation occurred intracellularly or the ecto-protein kinase assay was insufficiently sensitive. It is likely that an ecto-protein kinase plays a role in STC1 phosphorylation for two reasons. First, no cellular phosphorylated STC1 was detected. Secondly, the secreted form that was phosphorylated was also highly glycosylated and no highly glycosylated form was found in the cells. This suggests that this form of STC1 is destined for rapid secretion, while the major forms are stored. Ecto-PKC has been well characterized in a number of cell types [33] [34] [35] [36] [37] and phosphorylates a variety of proteins. Phosphorylation of peptide hormones by ecto-PKC has not previously been found. STC1 was, however, an in itro substrate for PKC. Phosphoamino acid analysis of STC1 immunoprecipitated from HT1080 cells metabolically labelled with radiolabelled phosphate or phosphorylated in itro by PKC indicated that STC1 is phosphorylated exclusively on serine residue(s) in both contexts. Further correlation between in i oand in itro-phosphorylated STC1 was observed when comparing the phosphopeptide maps, which were indistinguishable. Taken together, these data indicate that PKC is the best candidate for STC1 phosphorylation in i o.
Ecto-phosphorylation may play an important functional role for STC1 and STC2, as judged by its importance in regulation of other secreted phosphoproteins. Ecto-protein kinases, including ecto-PKA [16, 38] , ecto-PKC [35, 39] , ecto-CK2 [40, 41] and other unidentified protein kinases, have been observed on the outer surfaces of many cells. CK2 is perhaps the best-characterized ecto-protein kinase [31, 42] and is found on the surface of HeLa cells [40] , lymphocytes [43] and some bone cells [41] . In intact lymphocytes, ecto-CK2 plays a key role in cytotoxicity, as inhibition of ecto-CK2 abolishes target cell death [43] . Ecto-CK2 may also play a role in platelet activation [44] and has been shown to stimulate neurotransmitter uptake in neuronal cells [45] . It was positively identified as CK2 by Western blotting and by MALDI-TOF MS analysis of tryptic peptides [31] . Other suggested substrates for ecto-CK2 include fibrinogen [46] , blood coagulation factors Va and VIII [47] , the bone glycoproteins osteopontin and sialoprotein [41] and a variety of unidentified cell-surface proteins [31] . STC2 is the first peptide hormone found to be a substrate for ecto-CK2 protein kinase.
The biological role of STC1 and STC2 phosphorylation has yet to be determined ; however, the addition of one or more phosphate groups to other peptide hormones have been found to regulate hormone processing, structure and biological activity. During the processing of progastrin, phosphorylation determines prohormone cleavage rates and controls production of alternative active products [18] . Human chorionic gonadotropin, on the other hand, is phosphorylated both in cells and after secretion, this being regulated by phorbol esters and by dimers of α and β human chorionic gonadotropin [14] . Phosphorylation can change the conformation and subsequently affect hormone function by disrupting local ionic or steric interactions. Phosphorylation of prolactin causes unique structural changes determined by absorption and UV fluorescence spectroscopy [20, 21] . This reduces its receptor binding and is restored by dephosphorylation [22] . The phosphorylation of basic fibroblast growth factor in its receptor-binding domain by PKA increases its affinity for the fibroblast-growth-factor receptor [48] . The conformational change associated with phosphorylation may help increase the protein's half-life, as seen in fibrinogen digestion by plasmin [49] . The phosphorylation of growth hormone at Ser-90 severely reduces its biological activity [21] . This impairment is mimicked by substituting glutamic acid for Ser-90 [21] . In itro studies of fibrinogen show that phosphorylation increases fibre thickness in fibrin clots [50] .
In summary, this study demonstrates for the first time that STC1 and STC2 are secreted phosphoproteins as well as in itro substrates for PKC and CK2 respectively. The in itro CK2 phosphorylation site of STC2 was shown by MALDI-TOF MS to be a single serine located between Ser-285 and Ser-298 at the C-terminus. In addition, STC2 is able to be phosphorylated by an ecto-protein kinase with characteristics of CK2. The significance of phosphorylation observed for other secreted hormones suggests that the phosphorylation of the human STCs may be an important means of regulating their biological activity in calcium and phosphate homoeostasis.
